Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Biometrics. 2013 Aug 19;69(3):673–682. doi: 10.1111/biom.12065

Table 4.

Summary statistics for the hybrid design, greedy design, and non-adaptive balanced allocation, for the (3-dose, 2-schedule) trial. The “balanced” method assigns 12 patients to each (schedule, dose) pair and does only one posterior computation, at the end of the trial. The number in parentheses after each Rselect is the percentage of times the trial is stopped with no (schedule, dose) selected. Because scenarios 7 (too toxic) and 8 (too inefficacious) have no acceptable treatments, the Rselect values are less relevant and thus are shown with a gray background.

Scenario Hybrid Greedy Balanced
Rselect Rtreat Rselect Rtreat Rselect Rtreat




1 0.82 (1) 0.54 0.78 (1) 0.45 0.85 (0) 0.50
2 0.85 (1) 0.75 0.85 (1) 0.84 0.85 (0) 0.51
3 0.81 (1) 0.54 0.78 (1) 0.48 0.83 (0) 0.50
4 0.80 (1) 0.69 0.80 (0) 0.77 0.80 (0) 0.51
5 0.74 (1) 0.54 0.65 (1) 0.48 0.77 (0) 0.40
6 0.76 (2) 0.62 0.75 (3) 0.62 0.77 (0) 0.55
7 0.87 (100) 0.81 1.00 (100) 0.83 0.94 (98) 0.50
8 0.54 (96) 0.54 0.54 (96) 0.59 0.35 (72) 0.50